SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,490.00    -50.00 (-1.11%)
Bid:
4,400.00
Ask:
4,580.00
Spread: 180.00 (4.091%)
Market Cap: £296.40m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Total Voting Rights

2 Feb 2026 09:38

RNS Number : 3048R
Judges Scientific PLC
02 February 2026
 

Press Release

 

 

Judges Scientific plc

("Judges Scientific", "the Company", or "the Group")

Total Voting Rights

 

Judges Scientific confirms that, as at 31 January 2026, the total issued share capital has increased to 6,660,444 Ordinary shares of 5p each ("Ordinary Share").

 

There are no Ordinary Shares held in treasury. Each Ordinary Share carries voting rights on the basis of one vote per Ordinary Share. Therefore, the total number of voting rights in Judges Scientific is 6,660,444 Ordinary Shares.

 

The above figure may be used by shareholders as the denominator for calculations to determine if they have a notifiable interest in Judges Scientific under the Disclosure and Transparency Rules, or if such interest has changed.

- Ends - 

For further information please contact: 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

 

Panmure Liberum (Joint Broker)

Edward Mansfield

William King

Tel : +44 (0) 20 3100 2222

 

 

Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 20 7597 4000

Alma (Financial Public Relations)

Sam Modlin

Rebecca Sanders-Hewett

Joe Pederzolli

Sarah Peters

Tel: +44 (0) 20 3405 0205

judges@almastrategic.com

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 25 businesses acquired since 2005.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREANAAEDXKEEA
Date   Source Headline
7th Jun 20133:24 pmRNSDirector/PDMR Shareholding
29th May 20135:17 pmRNSResult of AGM
10th May 20134:06 pmRNSDirector/PDMR Shareholding
12th Apr 20133:30 pmRNSIssue of Equity
9th Apr 201311:59 amRNSDirector/PDMR Shareholding
22nd Mar 20137:00 amRNSFinal Results
8th Mar 201311:30 amRNSNotice of Results
7th Mar 20132:41 pmRNSDirector/PDMR Shareholding
8th Feb 20133:54 pmRNSDirector/PDMR Shareholding
24th Jan 20137:00 amRNSTrading Statement
17th Jan 201310:55 amRNSIssue of Equity
14th Jan 20132:43 pmRNSIssue of Equity
8th Jan 20133:24 pmRNSDirector/PDMR Shareholding
17th Dec 20122:11 pmRNSIssue of Equity
10th Dec 20123:28 pmRNSDirector/PDMR Shareholding and issue of equity
4th Dec 20123:06 pmRNSIssue of Equity
21st Nov 20127:00 amRNSTrading Statement
8th Nov 20125:22 pmRNSDirector/PDMR Shareholding
5th Nov 20122:24 pmRNSDirector/PDMR Shareholding
5th Nov 201210:14 amRNSDirector's Details
29th Oct 20122:22 pmRNSDirector/PDMR Shareholding
9th Oct 201212:05 pmRNSDirector/PDMR Shareholding
3rd Oct 20122:28 pmRNSHolding(s) in Company
25th Sep 20126:28 pmRNSHolding(s) in Company
25th Sep 20127:00 amRNSHalf Yearly Report
7th Sep 20123:19 pmRNSDirector/PDMR Shareholding
6th Sep 201211:31 amRNSNotice of Results
31st Aug 20129:52 amRNSHolding(s) in Company
24th Aug 20127:00 amRNSDirector/PDMR Shareholding
22nd Aug 20123:44 pmRNSHolding(s) in Company
21st Aug 20127:00 amRNSDirector/PDMR Shareholding
8th Aug 20123:13 pmRNSDirector/PDMR Shareholding
23rd Jul 20125:34 pmRNSDirector/PDMR Shareholding
18th Jul 20127:00 amRNSTrading Statement
9th Jul 20125:43 pmRNSDirector/PDMR Shareholding
29th Jun 201212:17 pmRNSDirector/PDMR Shareholding
29th Jun 20127:00 amRNSDirector/PDMR Shareholding
22nd Jun 20127:00 amRNSDirector/PDMR Shareholding
21st Jun 20125:17 pmRNSHolding(s) in Company
7th Jun 20124:36 pmRNSDirector/PDMR Shareholding
30th May 20125:16 pmRNSResult of AGM
22nd May 20126:18 pmRNSDirector/PDMR Shareholding
17th May 20123:31 pmRNSHolding(s) in Company
17th May 20123:16 pmRNSHolding(s) in Company
16th May 20125:14 pmRNSHolding(s) in Company
11th May 201212:07 pmRNSDirector/PDMR Shareholding
10th May 201210:00 amRNSIssue of Equity
9th May 201211:33 amRNSHolding(s) in Company
23rd Apr 20125:24 pmRNSExercise of Options
18th Apr 20125:46 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.